Results 11 to 20 of about 33,588 (309)
The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN [PDF]
BJUI CompassObjectives This work aims to present epidemiological data on penile cancer from the Nordic region (Denmark, Finland, Iceland, Norway, Sweden) and discuss the results in light of the present knowledge and possible future treatment strategies. Patients and
Christian Arvei Moen +5 more
doaj +2 more sources
Evaluation of C-reactive protein levels in patients with penile cancer: a systematic review and meta-analysis [PDF]
World Journal of Surgical OncologyBackground C-reactive protein (CRP) is an essential biomarker for evaluating penile cancer prognosis. Previous studies have reported conflicting outcomes concerning the correlation between CRP levels and penile cancer prognosis.
Tao Qin +6 more
doaj +2 more sources
Body mass index and penile cancer incidence: results from a Norwegian cohort study of 829,081 men [PDF]
BMC UrologyBackground A few previous studies have suggested a possible association between adiposity and increased risk of penile cancer, however, the evidence is to date limited for this rare cancer.
Dagfinn Aune +7 more
doaj +2 more sources
Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders [PDF]
Frontiers in OncologyPenile cancer is a rare malignant tumor of the male urinary system. The treatment benefit of standard first-line chemotherapy is not ideal for patients with locally advanced or metastatic lymph nodes.
Da-Ming Xu +6 more
doaj +2 more sources
Penile sparing therapy for penile cancer [PDF]
Translational Andrology and Urology, 2020 Penile cancer is a rare malignancy with a reported incidence of 0.66-1.44 per 100,000 men, and a reported mortality of 0.15-0.37 per 10,000 men. Expert clinical examination and histological diagnosis from biopsy is required to determine the extent and invasion of disease, which is paramount in planning of appropriate treatment.
Shomik Sengupta +2 more
openaire +3 more sources
Chemotherapy in Penile Cancer [PDF]
Therapeutic Advances in Urology, 2012 Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. While this squamous cell cancer responds to chemotherapy, successful treatment of lymphatic metastases can only be achieved with aggressive surgical treatment in combination with chemotherapy. However, because penile carcinoma is relatively rare there is a
Chris Protzel, Oliver W. Hakenberg
openaire +3 more sources
A Review of Penile Cancer [PDF]
Advances in Urology, 2009 Cancer of the penis is a rare tumour in Europe and mainly affects the elderly patient population. The aim of this paper was to analyse and study the characteristics of this tumour, in our patient population.Materials and Methods.A retrospective study was conducted on penile tumours diagnosed and treated in the Urology Department of the Hospital ...
A. Tabernero Gomez +5 more
openaire +3 more sources
Malignant priapism due to penile metastases. Case series and literature review [PDF]
, 2016 Malignant priapism secondary to penile metastases is a rare condition. This term was originally used by Peacock in 1938 to describe a condition of painful induration and erection of the penis due to metastatic infiltration by a neoplasm.
DE DOMINICIS, Carlo +7 more
core +5 more sources
Management of penile cancer [PDF]
Translational Andrology and Urology, 2017 Penile cancer remains a relatively infrequent malignancy in North America, Europe, and Asia nevertheless it is a devastating disease which portends an adverse prognosis in those presenting with advanced disease. Similarly, the clinical and surgical care remains highly diverse across many parts of the world often applying non-evidence based approaches ...
Philippe E. Spiess, Michael A. Poch
openaire +3 more sources
The retinoblastoma protein/p16INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma [PDF]
, 2011 Aims: The pathogenesis of penile squamous cell carcinoma (PSCC) is not well understood. Human papillomavirus (HPV) may be involved in carcinogenesis, but few studies have compared cell-cycle protein expression in HPV positive and negative cancers.
Backes +38 more
core +3 more sources